Orchid Pharma Gains 8.87%: 3 Key Factors Driving the Week’s Rally
2026-11-21 16:05:28Key Events This Week 16 Nov: Intraday high of Rs.980 with 7.09% surge 16 Nov: Significant gap up opening at +7.91% 17 Nov: Strong quarterly growth reported with 1383.4% PBT increase 20 Nov: Week closes at Rs.959.65, up 8.87% Week OpenRs.881.50 Week CloseRs.959.65<div class="stat-change po...
Read More
Orchid Pharma Ltd Reports Strong Quarterly Growth Amid Positive Financial Trend
2026-11-17 08:00:08Orchid Pharma Ltd has demonstrated a marked improvement in its financial performance for the quarter ended September 2026, signalling a positive shift in its financial trend. The company’s latest results reveal robust revenue growth, significant profit expansion, and an upgraded Mojo Grade, reflecting renewed investor confidence in this small-cap pharmaceutical player.
Read More
Orchid Pharma Ltd is Rated Hold by MarketsMOJO
2026-11-14 10:10:41Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Orchid Pharma Ltd is Rated Hold
2026-10-23 10:10:46Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 August 2026. While this rating change occurred in mid-August, the analysis and financial metrics discussed here reflect the stock's current position as of 23 October 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Orchid Pharma Ltd is Rated Hold
2026-10-12 10:10:44Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 August 2026. While this rating change reflects the company’s evolving outlook, the analysis below is based on the stock’s current fundamentals, returns, and financial metrics as of 12 October 2026, providing investors with an up-to-date perspective on its investment potential.
Read More
Orchid Pharma Ltd is Rated Hold
2026-10-01 10:11:07Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Orchid Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-09-29 08:04:18Orchid Pharma Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a bullish to a mildly bullish trend. Despite a recent decline in price, the stock’s mixed technical signals suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.
Read MoreOrchid Pharma Gains 7.66%: 3 Key Factors Driving the Week’s Momentum
2026-09-26 16:04:09Key Events This Week 21 Sep: Intraday high surge with 7.28% gain 22 Sep: New 52-week high at Rs.1,138 22 Sep: Mojo Grade upgraded to Hold, bullish technical momentum 25 Sep: Week closes at Rs.1,064.85, up 7.66% Week OpenRs.989.10 Week CloseRs.1,064.85+7.6...
Read More
Broad-Based Technical Strength Lifts Orchid Pharma Ltd to 52-Week High of Rs 1138
2026-09-22 10:18:23With a decisive break above Rs 1138 on 22 Sep 2026, Orchid Pharma Ltd has reached a new 52-week high, extending its impressive 47.86% gain over the past year. This milestone comes amid a sustained rally that has seen the stock outperform its sector by nearly 5% today and gain almost 19% over the last three sessions.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
20-Nov-2026 | Source : BSETranscript of Analysts/Investor Earning call held with Public at large on November 17 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
17-Nov-2026 | Source : BSEAudio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited (the Company)
Board Comments On The Fine Levied By Stock Exchanges
16-Nov-2026 | Source : BSEBoard Comments on fine levied by Stock Exchanges
Corporate Actions
No Upcoming Board Meetings
Orchid Pharma Ltd has declared 30% dividend, ex-date: 13 Sep 12
No Splits history available
No Bonus history available
No Rights history available